Crinecerfont Promising for Congenital Adrenal Hyperplasia

Oral corticotropin-releasing factor type 1 receptor antagonist enables glucocorticoid dosing at physiologic levels while maintaining androstenedione control.
Medscape Medical News

source https://www.medscape.com/viewarticle/crinecerfont-promising-congenital-adrenal-hyperplasia-2024a1000ab4?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost